Journal of Cardiovascular Disease Research
Serum AMH (Anti-Müllerian Hormone) as a predictor of Polycystic Ovarian Syndrome among the Women of Reproductive Age – a study in a tertiary care hospital
Kaushik Mahajan, Leimapokpam Roshan Singh
JCDR. 2023: 2823-2832
Abstract
Background: Anti-Müllerian Hormone (AMH) is multiple fold increased in PCOS women compared to normal women. The increase in AMH is due to an increase in the number of antral follicles which increases in response to gonadotropin hormone. This study aims to determine the specificity and sensitivity of AMH in the diagnosis of polycystic ovarian syndrome.
» PDF